Drug Database
Back to search

United States· US:68083-300_db27a30b-8264-4248-b83e-b6ba0feafbf0

Doxercalciferol

A doxercalciferol product containing doxercalciferol, registered in United States by Gland Pharma Limited.

ATC H05BX03US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedDoxercalciferolATCH05BX03REGISTER NO.US:68083-300_db27a30b…PACKS LISTED2CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about doxercalciferolAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
DOXERCALCIFEROL
Manufacturer
Gland Pharma Limited
Country
United States (US)
ATC code
H05BX03
ATC class
Doxercalciferol
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 27, 2026

Packs & prices · 2

  • ndc11
    68083-300-50
  • ndc11
    6808330050
    50 VIAL, SINGLE-DOSE in 1 CARTON (68083-300-50) / 2 mL in 1 VIAL, SINGLE-DOSE (68083-300-01)

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

82 interactions on record for doxercalciferol.

Graded by severity as the source publishes them — 12 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check doxercalciferol against other medicinesHow interaction checks work

Doxercalciferol · interactions on record

82 records

  • 12 severe
  • 69 moderate
  • 1 minor

Most severe, free to view

  • SucralfateA02BX02severe
  • ErgocalciferolA11CC01severe
  • DihydrotachysterolA11CC02severe
  • CalcitriolA11CC04severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under H05BX03

Doxercalciferol, as other registers publish it.

All doxercalciferol products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7e436626-59d5-4b83-b68f-6e8648e4d21e
GET /v1/drugs/7e436626-59d5-4b83-b68f-6e8648e4d21e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "route": "INTRAVENOUS",
  "source": "ndc",
  "strength": "4",
  "substance": "DOXERCALCIFEROL",
  "productndc": "68083-300",
  "dosage_form": "INJECTION, SOLUTION",
  "dea_schedule": null,
  "strength_unit": "ug/2mL",
  "application_number": "ANDA210452",
  "marketing_category": "ANDA"
}
API referenceMCP serverPlans

See everything about doxercalciferol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console